Medigene AG (MDG1) — Long-term Investment Intensity
Medigene AG (MDG1) has a Long-term Investment Intensity of 3.0% as of September 2019. Long-term investments of €3.47 Million represent 3.0% of total assets of €117.39 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check MDG1 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Medigene AG Long-term Investment Intensity (2013–2018)
This chart shows how Medigene AG's Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2018. As of September 2019, the intensity stands at 3.0%, reflecting long-term investments of €3.47 Million against total assets of €117.39 Million EUR. Explore Medigene AG cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Medigene AG (2013–2018)
The table below presents the year-by-year Long-term Investment Intensity for Medigene AG from 2013 to 2018, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see MDG1 company net worth.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 19.6% | €25.43 Million | €129.59 Million | ▲ +14.7 pp |
| 2017 | 4.9% | €5.49 Million | €111.94 Million | ▼ -0.2 pp |
| 2016 | 5.1% | €5.67 Million | €111.72 Million | ▼ -6.2 pp |
| 2015 | 11.3% | €12.82 Million | €113.53 Million | ▲ +2.3 pp |
| 2014 | 9.0% | €6.40 Million | €71.28 Million | ▼ -2.5 pp |
| 2013 | 11.5% | €6.05 Million | €52.66 Million | — |